Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro Infantil Boldrini is a premier philanthropic hospital and research institution dedicated to pediatric oncology and hematology, based in Campinas, Brazil. Established in 1978 by Dr. Silvia Brandalise, the center has become a Latin American benchmark for the treatment of childhood cancer and blood diseases, such as leukemia and sickle cell anemia. The organization operates a high-complexity hospital alongside a specialized research center that conducts advanced studies in molecular biology, genetics, and epidemiology. Boldrini is distinguished by its multidisciplinary approach to care, integrating medical treatment with social and psychological support for patients and their families. As a non-profit entity, it provides state-of-the-art medical services primarily through the Brazilian public health system. The institution is renowned for its high cure rates and its commitment to scientific advancement in the field of pediatric hematology-oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro Infantil Boldrini.